Drug intelligence / Profile preview

Catrix

Development stage
Unknown
Lead developer
Lescarden
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral, Topical, Ophthalmic
01

Overview

Catrix is a brand name associated with three distinct pharmaceutical products. One formulation is an oral tablet containing **aceclofenac**, a non-steroidal anti-inflammatory drug (NSAID) that preferentially inhibits cyclooxygenase-2 (COX-2) to treat pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. A second product is a topical **bovine cartilage powder** used as a biological dressing for wound healing in pressure ulcers, venous stasis ulcers, diabetic ulcers, and burns; it promotes healing by stimulating the growth of fibroblasts and keratinocytes. A third version is an **ophthalmic solution** containing anhydrous sodium succinate and cytochrome C, developed by Incepta Pharmaceuticals for the treatment of lens opacification (cataracts) by supporting cellular metabolism and providing antioxidant effects.

Brand names
Catrix
Other names
aceclofenacbovine cartilage powderanhydrous sodium succinate + cytochrome C
02

Targets

SDH (Mitochondrial electron transport chain complex II)PGHS-1 (Prostaglandin G/H Synthase 1)CYCS (Cytochrome c)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Catrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call